Stay updated on Radiotherapy and Pembrolizumab in Metastatic HNSCC Clinical Trial
Sign up to get notified when there's something new on the Radiotherapy and Pembrolizumab in Metastatic HNSCC Clinical Trial page.

Latest updates to the Radiotherapy and Pembrolizumab in Metastatic HNSCC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange Detected- Results Submitted added to the study record, and the revision updated to v3.3.2, replacing No Results Posted and v3.2.0.SummaryDifference0.1%

- Check28 days agoChange DetectedThe notification about government funding and operating status was removed from the page; this does not affect the study details, eligibility criteria, endpoints, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check49 days agoChange DetectedNo significant changes were detected on the page; the content and layout remain as before. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check70 days agoChange DetectedUpdate: new operating-status notice and v3.2.0 release; removes the old v3.1.0 tag.SummaryDifference3%

- Check78 days agoChange DetectedPage now updates to v3.1.0 and removes the Head and neck squamous cell carcinoma resource under Genetic and Rare Diseases Information Center resources; no other major content changes.SummaryDifference0.5%

- Check92 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2. The 'Back to Top' link was removed; no other substantive content changes detected.SummaryDifference0.2%

Stay in the know with updates to Radiotherapy and Pembrolizumab in Metastatic HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Radiotherapy and Pembrolizumab in Metastatic HNSCC Clinical Trial page.